https://scholars.lib.ntu.edu.tw/handle/123456789/520052
標題: | Risk of intracranial hemorrhage from statin use in Asians: A nationwide cohort study | 作者: | CHIA-HSUIN CHANG CHIN-HSIEN LIN Caffrey J.L. Lee Y.-C. Liu Y.-C. JOU-WEI LIN Lai M.-S. |
公開日期: | 2015 | 出版社: | Lippincott Williams and Wilkins | 卷: | 131 | 期: | 23 | 起(迄)頁: | 2070-2078 | 來源出版物: | Circulation | 摘要: | Background-Reports of statin usage and increased risk of intracranial hemorrhage (ICH) have been inconsistent. This study examined potential associations between statin usage and the risk of ICH in subjects without a previous history of stroke. Methods and Results-Patients initiating statin therapy between 2005 and 2009 without a previous history of ischemic or hemorrhagic stroke were identified from Taiwan's National Health Insurance database. Participants were stratified by advanced age (?70 years), sex, and diagnosed hypertension. The outcome of interest was hospital admission foRiCH (International Classification of Diseases, Ninth Revision, Clinical Modification codes 430, 431, 432). Cox regression models were applied to estimate the hazard ratio of ICH. The cumulative statin dosage stratified by quartile and adjusted for baseline disease risk score served as the primary variable using the lowest quartile of cumulative dosage as a reference. There were 1 096 547 statin initiators with an average follow-up of 3.3 years. The adjusted hazard ratio foRiCH between the highest and the lowest quartile was nonsignificant at 1.06 with a 95% confidence interval spanning 1.00 (0.94-1.19). Similar nonsignificant results were found in sensitivity analyses using different outcome definitions or model adjustments, reinforcing the robustness of the study findings. Subgroup analysis identified an excess of ICH frequency in patients without diagnosed hypertension (adjusted hazard ratio 1.36 [1.11-1.67]). Conclusions-In general, no association was observed between cumulative statin use and the risk of ICH among subjects without a previous history of stroke. An increased risk was identified among the nonhypertensive cohort, but this finding should be interpreted with caution. ? 2015 American Heart Association, Inc. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84936138660&doi=10.1161%2fCIRCULATIONAHA.114.013046&partnerID=40&md5=e294d2b3cba52fdac59f86e576d60e3d https://scholars.lib.ntu.edu.tw/handle/123456789/520052 |
ISSN: | 0009-7322 | DOI: | 10.1161/CIRCULATIONAHA.114.013046 | SDG/關鍵字: | hydroxymethylglutaryl coenzyme A reductase inhibitor; hydroxymethylglutaryl coenzyme A reductase inhibitor; adult; aged; Article; Asian; brain hemorrhage; brain ischemia; drug use; female; follow up; hazard ratio; hospital admission; human; hypertension; major clinical study; male; priority journal; risk assessment; sensitivity analysis; Taiwan; Cardiovascular Diseases; cohort analysis; dose response; hypercholesterolemia; incidence; Intracranial Hemorrhages; middle aged; proportional hazards model; retrospective study; risk factor; Cardiovascular Diseases; Cohort Studies; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Incidence; Intracranial Hemorrhages; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; Risk Factors; Taiwan |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。